Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease, Proc Natl Acad Sci U S A, vol.99, pp.15661-15668, 2002. ,
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, pp.6025-6030, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00395910
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.461, pp.399-401, 2009. ,
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C, Clinical Microbiology Reviews, vol.20, pp.23-38, 2007. ,
Hepatitis: HCV variability, the immune system and resistance to antiviral drugs, Nat Rev Gastroenterol Hepatol, vol.6, pp.383-385, 2009. ,
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy, Journal of Medical Virology, vol.81, pp.2029-2035, 2009. ,
Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus, Hepatology, vol.53, pp.1742-1751, 2011. ,
Antiviral strategies in hepatitis C virus infection, Journal of Hepatology, vol.56, pp.88-100, 2012. ,
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo, Gastroenterology, vol.132, pp.667-678, 2007. ,
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity, Journal of Virology, vol.83, pp.6149-6160, 2009. ,
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, The Journal of Experimental Medicine, vol.207, pp.2019-2031, 2010. ,
Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies, Gastroenterology, vol.143, pp.223-233, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00701511
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies, Journal of hepatology, vol.54, pp.566-576, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00701487
Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions, Journal of Virology, vol.78, pp.9224-9232, 2004. ,
Inhibition of the Interferon-Inducible Protein Kinase PKR by HCV E2, Protein. Science, vol.285, pp.107-110, 1999. ,
Hepatitis C Virus Envelope Glycoprotein Signatures Are Associated With Treatment Failure and Modulation of Viral Entry and Neutralization, Journal of Infectious Diseases, vol.207, pp.1306-1315, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02014345
Correlation of co-ordinated amino acid substitutions with function in viruses related to tobacco mosaic virus, Journal of Molecular Biology, vol.193, pp.693-707, 1987. ,
Correlated mutations and residue contacts in proteins, Proteins, vol.18, pp.309-317, 1994. ,
A pair-to-pair amino acids substitution matrix and its applications for protein structure prediction, Proteins, vol.67, pp.142-153, 2007. ,
Analysis of the residue-residue coevolution network and the functionally important residues in proteins, Proteins: Structure, Function, and Bioinformatics, vol.72, pp.863-872, 2008. ,
Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans, The Journal of Clinical Investigation, vol.119, pp.225-236, 2009. ,
Integer and combinatorial optimization, 1988. ,
Hepatitis C virus-related resistance mechanisms to interferon [alpha]-based antiviral therapy, Journal of Clinical Virology, vol.32, pp.86-91, 2005. ,
Crossgenotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes, Journal of General Virology, vol.88, pp.458-469, 2007. ,
The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule, PLoS Pathog, vol.6, p.1000762, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00460826
Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein, Virology, vol.352, pp.357-367, 2006. ,
Coevolution of the Hepatitis C Virus Polyprotein Sites in Patients on Combined Pegylated Interferon and Ribavirin Therapy, Journal of Virology, vol.85, pp.3649-3663, 2011. ,
The Collaborative Study G (1997) Hepatitis C in a French population-based survey, 1994: Seroprevalence, frequency of viremia, genotype distribution, and risk factors, Hepatology, vol.25, pp.1490-1496 ,
A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope, Journal of Virology, vol.82, pp.6067-6072, 2008. ,